Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5781)
  3. Review (421)
  4. Editorial (196)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13278)
  2. Center for Hematologic Malignancies (10612)
  3. GSK Faculty (4482)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2705)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (340)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (292)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Subcutaneous epcoritamab in patients with Richter's syndrome: Early results from phase 1b/2 trial (EPCORE CLL-1)
    Meeting Abstract

    Kater, A. P.; Ye, J. C.; Sandoval-Sus, J.; Bellido, M.; Christensen, J. H.; Mato, A. R.; Janssens, A.; Oki, T.; Hoehn, D.; Rios, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Prevalence of MGUS is high in the iStopMM study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do
    Meeting Abstract

    Love, T. J.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Aspelund, T.; Reed, E. R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The high mobility group A1 chromatin regulator drives immune evasion during MPN progression by repressing genes involved in antigen presentation
    Meeting Abstract

    Kim, J.; Kim, J. H.; Cope, L.; Li, L.; Rampal, R. K.; Koche, R.; Spivak, J. L.; Moliterno, A. R.; Resar, L.
    Blood (2022)

    Fulltext@MSK | Save
  • The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study
    Meeting Abstract

    Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Molecular features associated with response to combination therapy with enasidenib (ENA) plus azacitidine (AZA) in newly diagnosed IDH2-mutated acute myeloid leukemia (AML)
    Meeting Abstract

    Risueño, A.; See, W. L.; DiNardo, C. D.; Döhner, H.; Stein, E.; Fathi, A. T.; Vyas, P.; Quek, L.; Prebet, T.; Gandhi, A. K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predicting the need for upfront bone marrow sampling in individuals with MGUS: Derivation of a multivariable prediction model using the prospective population-based iStopMM cohort
    Meeting Abstract

    Eythorsson, E.; Rögnvaldsson, S.; Thorsteinsdóttir, S.; Reed, E. R.; Sigurdardóttir, G. Á.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardóttir, M.; Ólafsson, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Analysis of 372 adult allograft recipients reveals associations between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate grafts
    Meeting Abstract

    Fingrut, W.; Chinapen, S.; Katrichis, A.; Carino, C.; Davis, E.; Shaffer, B. C.; Cho, C.; Shah, G. L.; Barker, J. N.
    Blood (2022)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): Real world outcomes in a multicenter retrospective study
    Meeting Abstract

    Qualls, D.; Buege, M. J.; Dao, P.; Caimi, P. F.; Rutherford, S. C.; Wehmeyer, G.; Romancik, J. T.; Leslie, L. A.; Merrill, M. H.; Crombie, J. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Characteristics and prognostic effects of DNMT3A co-mutations
    Meeting Abstract

    Torabi, A.; Alonzo, T. A.; Othus, M.; Gerbing, R. B.; Wang, Y. C.; Ries, R. E.; Radich, J. P.; Appelbaum, F. R.; O'Dwyer, K.; Erba, H. P.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save